Genetically Modified Human Bone Marrow Derived Mesenchymal Stem Cells for Improving the Outcome of Human Islet Transplantation

被引:13
作者
Mundra, Vaibhav [1 ]
Wu, Hao [1 ]
Mahato, Ram I. [1 ]
机构
[1] Univ Tennessee, Ctr Hlth Sci, Dept Pharmaceut Sci, Memphis, TN 38163 USA
来源
PLOS ONE | 2013年 / 8卷 / 10期
基金
美国国家卫生研究院;
关键词
ENDOTHELIAL GROWTH-FACTOR; IN-VITRO; PANCREATIC-ISLETS; GENE-TRANSFER; BETA-CELLS; CYTOKINES ACTIVATE; EXPRESSION; APOPTOSIS; DIFFERENTIATION; PROLIFERATION;
D O I
10.1371/journal.pone.0077591
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The objective of this study was to determine the potential of human bone marrow derived mesenchymal stem cells (hBMSCs) as gene carriers for improving the outcome of human islet transplantation. hBMSCs were characterized for the expression of phenotypic markers and transduced with Adv-hVEGF-hIL-1Ra to overexpress human vascular endothelial growth factor (hVEGF) and human interleukin-1 receptor antagonist (hIL-1Ra). Human islets were co-cultured with hBMSCs overexpressing hVEGF and hIL-1Ra. Islet viability was determined by membrane fluorescent method and glucose stimulation test. Transduced hBMSCs and human islets were co-transplanted under the kidney capsule of NOD.Cg-Prkdc(scid) Il2rg(tm1Wjl)/SzJ (NSG) diabetic mice and blood glucose levels were measured over time to demonstrate the efficacy of genetically modified hBMSCs. At the end of study, immunofluorescent staining of kidney section bearing islets was performed for insulin and von Willebrand Factor (vWF). hBMSCs were positive for the expression of CD73, CD90, CD105, CD146 and Stro-1 surface markers as determined by flow cytometry. Transduction of hBMSCs with adenovirus did not affect their stemness and differentiation potential as confirmed by mRNA levels of stem cell markers and adipogenic differentiation of transduced hBMSCs. hBMSCs were efficiently transduced with Adv-hVEGF-hIL-1Ra to overexpress hVEGF and hIL-1Ra. Live dead cell staining and glucose stimulation test have shown that transduced hBMSCs improved the viability of islets against cytokine cocktail. Co-transplantation of human islets with genetically modified hBMSCs improved the glycemic control of diabetic NSG mice as determined by mean blood glucose levels and intraperitoneal glucose tolerance test. Immunofluorescent staining of kidney sections was positive for human insulin and vWF. In conclusion, our results have demonstrated that hBMSCs may be used as gene carriers and nursing cells to improve the outcome of islet transplantation.
引用
收藏
页数:10
相关论文
共 51 条
[1]   Cytokines activate caspase-3 in insulinoma cells of diabetes-prone NOD mice directly and via upregulation of Fas [J].
Augstein, P ;
Bahr, J ;
Wachlin, G ;
Heinke, P ;
Berg, S ;
Salzsieder, E ;
Harrison, LC .
JOURNAL OF AUTOIMMUNITY, 2004, 23 (04) :301-309
[2]   Inflammation-mediated dysfunction and apoptosis in pancreatic islet transplantation: implications for intrahepatic grafts [J].
Barshes, NR ;
Wyllie, S ;
Goss, JA .
JOURNAL OF LEUKOCYTE BIOLOGY, 2005, 77 (05) :587-597
[3]   Mesenchymal Stem Cells Enhance Allogeneic Islet Engraftment in Nonhuman Primates [J].
Berman, Dora M. ;
Willman, Melissa A. ;
Han, Dongmei ;
Kleiner, Gary ;
Kenyon, Norman M. ;
Cabrera, Over ;
Karl, Julie A. ;
Wiseman, Roger W. ;
O'Connor, David H. ;
Bartholomew, Amelia M. ;
Kenyon, Norma S. .
DIABETES, 2010, 59 (10) :2558-2568
[4]   Succesful transplantation of human islets in recipients bearing a kidney graft [J].
Bertuzzi, F ;
Grohovaz, F ;
Maffi, P ;
Caumo, A ;
Aldrighetti, L ;
Nano, R ;
Hengster, P ;
Calori, G ;
Di Carlo, V ;
Bonifacio, E ;
Secchi, A .
DIABETOLOGIA, 2002, 45 (01) :77-84
[5]   β-cell death and mass in syngeneically transplanted islets exposed to short- and long-term hyperglycemia [J].
Biarnés, M ;
Montolio, M ;
Nacher, V ;
Raurell, M ;
Soler, J ;
Montanya, E .
DIABETES, 2002, 51 (01) :66-72
[6]   Intraislet endothelial cells contribute to revascularization of transplanted pancreatic islets [J].
Brissova, M ;
Fowler, M ;
Wiebe, P ;
Shostak, A ;
Shiota, M ;
Radhika, A ;
Lin, PC ;
Gannon, M ;
Powers, AC .
DIABETES, 2004, 53 (05) :1318-1325
[7]   Enhanced expression of VEGF-A in β cells increases endothelial cell number but impairs islet morphogenesis and β cell proliferation [J].
Cai, Qing ;
Brissova, Marcela ;
Reinert, Rachel B. ;
Pan, Fong Cheng ;
Brahmachary, Priyanka ;
Jeansson, Marie ;
Shostak, Alena ;
Radhika, Aramandla ;
Poffenberger, Greg ;
Quaggin, Susan E. ;
Jerome, W. Gray ;
Dumont, Daniel J. ;
Powers, Alvin C. .
DEVELOPMENTAL BIOLOGY, 2012, 367 (01) :40-54
[8]   Cytokines induce deoxyribonucleic acid strand breaks and apoptosis in human pancreatic islet cells [J].
Delaney, CA ;
Pavlovic, D ;
Hoorens, A ;
Pipeleers, DG ;
Eizirik, DL .
ENDOCRINOLOGY, 1997, 138 (06) :2610-2614
[9]   Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement [J].
Dominici, M. ;
Le Blanc, K. ;
Mueller, I. ;
Slaper-Cortenbach, I. ;
Marini, F. C. ;
Krause, D. S. ;
Deans, R. J. ;
Keating, A. ;
Prockop, D. J. ;
Horwitz, E. M. .
CYTOTHERAPY, 2006, 8 (04) :315-317
[10]   Preparatory studies of composite mesenchymal stem cell islets for application in intraportal islet transplantation [J].
Duprez, Ida Rasmusson ;
Johansson, Ulrika ;
Nilsson, Bo ;
Korsgren, Olle ;
Magnusson, Peetra U. .
UPSALA JOURNAL OF MEDICAL SCIENCES, 2011, 116 (01) :8-17